Basic info
Industry
biotechnology research
Sectors
Biotechnology
Cancer
Sickle Cell Disease
Engineered Cell Medicines
Hematopoietic Stem Cells
Rare Diseases
Blood Diseases
Health Care
Transfusion-Dependent Beta Thalassemia
In Vivo (in body) Editing
Genetic Diseases
Immunogenetics
Genome Editing
Ocular Medicines
Genetics
Medical
Date founded
2013
Funding rounds raised
Total raised
$120M
from 15 investors over 15 rounds
E
Editas Medicine raised $120M on August 10, 2015
Investors: Omega Funds, Third Rock Ventures, Khosla Ventures, GV, Flagship Ventures, Viking Global Investors, Polaris Partners, Jennison Associates LLC, Innova Capital and T. Rowe Price
E
Editas Medicine raised $47M on May 27, 2015
Investors: Juno Therapeutics, Inc.
E
Editas Medicine raised $43M on November 25, 2013
Investors: Third Rock Ventures, Flagship Ventures, Partners HealthCare and Polaris Partners